Related Experiment Video
Updated: Jun 27, 2026
07:32
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
New horizons in adjuvants for vaccine development
Steven G Reed1, Sylvie Bertholet, Rhea N Coler
1Infectious Disease Research Institute, 1124 Columbia St. Suite 400, Seattle, WA 98104, USA.
Trends in Immunology
|December 9, 2008
Summary
Novel vaccine adjuvants are improving immune responses, but successful development requires understanding adjuvant formulation. This review details current adjuvant research and formulation impacts on vaccine effectiveness.
Area of Science:
- Vaccinology
- Immunology
- Biopharmaceutical Formulation
Background:
- Significant advancements in vaccine adjuvant research have occurred over the past decade.
- Several novel adjuvants are now incorporated into licensed vaccines or are in advanced clinical trials.
- The efficacy of adjuvants in boosting immune responses to recombinant antigens has redirected vaccine development strategies.
Purpose of the Study:
- To review the current landscape of adjuvant research and development in vaccinology.
- To elucidate how formulation parameters critically influence adjuvant effectiveness and vaccine immunogenicity.
- To address the information gap regarding adjuvant selection and formulation for vaccine researchers.
Main Methods:
- Comprehensive literature review of recent studies on vaccine adjuvants.
- Analysis of formulation strategies and their impact on adjuvant-antigen interactions.
- Synthesis of data on adjuvant stability, safety, and immunogenicity.
Main Results:
- Adjuvant technology has progressed significantly, with new options available for vaccine design.
- Formulation parameters such as antigen-adjuvant ratios, delivery systems, and physicochemical properties are key determinants of vaccine performance.
- Challenges remain in accessing well-characterized adjuvants and comprehensive formulation guidelines.
Conclusions:
- Adjuvant selection and precise formulation are critical for developing stable, safe, and effective vaccines.
- Further research and accessible resources are needed to optimize adjuvant use in vaccine development.
- Understanding formulation science is essential for harnessing the full potential of modern vaccine adjuvants.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.